The percentage of altered tumor cells in relation to the PDL1/2 locus ranged from 29% (2/7) in gastric DLBCL to 61% (14/23) in CNS lymphoma and 75% (3/4) in bone extranodal DLBCL. The gene discussed is CD274; the disease is neoplasm.